Autologous plasmin
Alternative Names: Autologous fibrinolysin human; Autologous plasmin - Oxurion/NuVue; Autologous plasmin enzyme; Recombinant autologous plasminLatest Information Update: 11 Sep 2018
At a glance
- Originator ThromboGenics
- Developer NuVue Technologies; ThromboGenics
- Class Serine endopeptidases; Thrombolytics
- Mechanism of Action Serine endopeptidase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Eye disorders
Most Recent Events
- 10 Sep 2018 Thrombogenics is now called Oxurion
- 10 Mar 2004 Clinical trials in Eye disorders in USA (unspecified route)